Global Information
회사소개 | 문의 | 비교리스트

세계 및 대만의 조루 치료 시장 : 규모, 상황, 예측(2021-2027년)

Global and Taiwan Premature Ejaculation Treatment Market Size, Status and Forecast 2021-2027

리서치사 QYResearch
발행일 2021년 05월 상품코드 1006744
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 3,900 ₩ 5,540,000 PDF (Single User License)
US $ 5,850 ₩ 8,310,000 PDF (Multi User License)
US $ 7,800 ₩ 11,080,000 PDF (Enterprise User License)


세계 및 대만의 조루 치료 시장 : 규모, 상황, 예측(2021-2027년) Global and Taiwan Premature Ejaculation Treatment Market Size, Status and Forecast 2021-2027
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 조루 치료 시장 규모는 2020년 26억 4,648만 달러에서 2027년 말까지 48억 6,510만 달러에 달하고, 2021-2027년 CAGR로 9.23%의 성장이 예측됩니다.

대만의 조루 치료 시장 규모는 2020년 1,818만 달러에서 2027년까지 4,114만 달러에 달하고, 예측기간 중 CAGR로 12.89%의 성장이 예측됩니다.

세계 및 대만의 조루 치료(Premature Ejaculation Treatment) 시장에 대해 조사 분석했으며, 시장 규모(실적과 예측)와 상황에 대한 체계적인 정보를 제공합니다.

목차

제1장 보고서 개요

제2장 세계의 성장 동향

  • 세계의 조루 치료 시장 전망
  • 조루 치료 성장 동향 : 지역별
  • 조루 치료 업계의 동향

제3장 마이크로 환경 분석

  • 아시아 시장 분석
  • 대만 시장 분석
  • 세계·지역별 조루 데이터 팩트
  • 환자 여정 매핑

제4장 경쟁 상황 : 주요 기업별

  • 세계의 조루 치료 주요 기업 : 매출별
  • 세계의 조루 치료 시장 점유율 : 기업 종류별
  • 대상 기업 : 조루 치료 매출별 순위
  • 세계의 조루 치료 시장 집중도
  • 조루 치료 주요 기업의 본사와 제공 지역
  • 주요 기업의 조루 치료 제품 솔루션과 서비스
  • 조루 치료 시장 진출 시기
  • 인수합병, 확장 계획

제5장 조루 치료 내역 데이터 : 종류별

  • 세계의 조루 치료 과거 시장 규모 : 종류별
  • 세계의 조루 치료 시장 규모 예측 : 종류별

제6장 조루 치료 내역 데이터 : 용도별

  • 세계의 조루 치료 과거 시장 규모 : 용도별
  • 세계의 조루 치료 시장 규모 예측 : 용도별

제7장 북미

  • 북미의 조루 치료 시장 규모
  • 북미의 조루 치료 시장 규모 : 종류별
  • 북미의 조루 치료 시장 규모 : 용도별
  • 북미의 조루 치료 시장 규모 : 국가별
    • 미국
    • 캐나다

제8장 유럽

  • 유럽의 조루 치료 시장 규모
  • 유럽의 조루 치료 시장 규모 : 종류별
  • 유럽의 조루 치료 시장 규모 : 용도별
  • 유럽의 조루 치료 시장 규모 : 국가별
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 러시아

제9장 아시아태평양

  • 아시아태평양의 조루 치료 시장 규모
  • 아시아태평양의 조루 치료 시장 규모 : 종류별
  • 아시아태평양의 조루 치료 시장 규모 : 용도별
  • 아시아태평양의 조루 치료 시장 규모 : 지역별
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 대만

제10장 라틴아메리카

  • 라틴아메리카의 조루 치료 시장 규모
  • 라틴아메리카의 조루 치료 시장 규모 : 종류별
  • 라틴아메리카의 조루 치료 시장 규모 : 용도별
  • 라틴아메리카의 조루 치료 시장 규모 : 국가별
    • 멕시코
    • 브라질

제11장 중동 및 아프리카

  • 중동 및 아프리카의 조루 치료 시장 규모
  • 중동 및 아프리카의 조루 치료 시장 규모 : 종류별
  • 중동 및 아프리카의 조루 치료 시장 규모 : 용도별
  • 중동 및 아프리카의 조루 치료 시장 규모 : 국가별
    • 중동
    • 아프리카

제12장 주요 기업 개요

  • Pfizer
  • Bayer
  • Novartis
  • Vivus
  • Menarini
  • Eli Lilly
  • Johnson &Johnson
  • GlaxoSmithKline
  • Torrent Pharma
  • Teva
  • Sunrise Pharma
  • Regent Pacific

제13장 애널리스트의 견해/결론

제14장 부록

KSM 21.06.16

List of Tables and Figures

  • Table 1. Global Premature Ejaculation Treatment Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027
  • Table 2. Key Players of Antidepressants(SSRIs)
  • Table 3. Key Players of Phosphodiesterase-5 Inhibitors
  • Table 4. Key Players of Topical Anesthetics
  • Table 5. Global Premature Ejaculation Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
  • Table 6. Global Premature Ejaculation Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
  • Table 7. Global Premature Ejaculation Treatment Market Size by Regions (2016-2021) & (US$ Million)
  • Table 8. Global Premature Ejaculation Treatment Market Share by Regions (2016-2021)
  • Table 9. Global Premature Ejaculation Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
  • Table 10. Global Premature Ejaculation Treatment Market Share by Regions (2022-2027)
  • Table 11. Premature Ejaculation Treatment Trends
  • Table 12. Premature Ejaculation Market Trends
  • Table 13. Premature Ejaculation Treatment Market Drivers
  • Table 14. Premature Ejaculation Treatment Market Challenges
  • Table 15. Premature Ejaculation Treatment Market Restraints
  • Table 16. Global and Region Premature Ejaculation Prevalence Rate(%) & Diagnosis Rate(%) & Under-Treatment Rate(%) in 2020
  • Table 17. Global Premature Ejaculation Treatment Revenue by Players (2016-2021) & (US$ Million)
  • Table 18. Global Premature Ejaculation Treatment Market Share by Players (2016-2021)
  • Table 19. Global Top Premature Ejaculation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Ejaculation Treatment as of 2020)
  • Table 20. Ranking of Global Top Premature Ejaculation Treatment Companies by Revenue (US$ Million) in 2020
  • Table 21. Global 5 Largest Players Market Share by Premature Ejaculation Treatment Revenue (CR5 and HHI) & (2016-2021)
  • Table 22. Key Players Headquarters and Area Served
  • Table 23. Key Players Premature Ejaculation Treatment Product Solution and Service
  • Table 24. Date of Enter into Premature Ejaculation Treatment Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Premature Ejaculation Treatment Market Size by Type (2016-2021) & (US$ Million)
  • Table 27. Global Premature Ejaculation Treatment Revenue Market Share by Type (2016-2021)
  • Table 28. Global Premature Ejaculation Treatment Forecasted Market Size by Type (2022-2027) & (US$ Million)
  • Table 29. Global Premature Ejaculation Treatment Revenue Market Share by Type (2022-2027)
  • Table 30. Global Premature Ejaculation Treatment Market Size by Application (2016-2021) & (US$ Million)
  • Table 31. Global Premature Ejaculation Treatment Revenue Market Share by Application (2016-2021)
  • Table 32. Global Premature Ejaculation Treatment Forecasted Market Size by Application (2022-2027) & (US$ Million)
  • Table 33. Global Premature Ejaculation Treatment Revenue Market Share by Application (2022-2027)
  • Table 34. North America Premature Ejaculation Treatment Market Size by Type (2016-2021) & (US$ Million)
  • Table 35. North America Premature Ejaculation Treatment Market Share by Type (2016-2021)
  • Table 36. North America Premature Ejaculation Treatment Market Size by Application (2016-2021) & (US$ Million)
  • Table 37. North America Premature Ejaculation Treatment Market Share by Application (2016-2021)
  • Table 38. North America Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
  • Table 39. North America Premature Ejaculation Treatment Market Share by Country (2016-2021)
  • Table 40. Europe Premature Ejaculation Treatment Market Size by Type (2016-2021) & (US$ Million)
  • Table 41. Europe Premature Ejaculation Treatment Market Share by Type (2016-2021)
  • Table 42. Europe Premature Ejaculation Treatment Market Size by Application (2016-2021) & (US$ Million)
  • Table 43. Europe Premature Ejaculation Treatment Market Share by Application (2016-2021)
  • Table 44. Europe Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
  • Table 45. Europe Premature Ejaculation Treatment Market Share by Country (2016-2021)
  • Table 46. Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2016-2021) & (US$ Million)
  • Table 47. Asia-Pacific Premature Ejaculation Treatment Market Share by Type (2016-2021)
  • Table 48. Asia-Pacific Premature Ejaculation Treatment Market Size by Application (2016-2021) & (US$ Million)
  • Table 49. Asia-Pacific Premature Ejaculation Treatment Market Share by Application (2016-2021)
  • Table 50. Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2016-2021) & (US$ Million)
  • Table 51. Asia-Pacific Premature Ejaculation Treatment Market Share by Region (2016-2021)
  • Table 52. Latin America Premature Ejaculation Treatment Market Size by Type (2016-2021) & (US$ Million)
  • Table 53. Latin America Premature Ejaculation Treatment Market Share by Type (2016-2021)
  • Table 54. Latin America Premature Ejaculation Treatment Market Size by Application (2016-2021) & (US$ Million)
  • Table 55. Latin America Premature Ejaculation Treatment Market Share by Application (2016-2021)
  • Table 56. Latin America Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
  • Table 57. Latin America Premature Ejaculation Treatment Market Share by Country (2016-2021)
  • Table 58. Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2016-2021) & (US$ Million)
  • Table 59. Middle East & Africa Premature Ejaculation Treatment Market Share by Type (2016-2021)
  • Table 60. Middle East & Africa Premature Ejaculation Treatment Market Size by Application (2016-2021) & (US$ Million)
  • Table 61. Middle East & Africa Premature Ejaculation Treatment Market Share by Application (2016-2021)
  • Table 62. Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2016-2021) & (US$ Million)
  • Table 63. Middle East & Africa Premature Ejaculation Treatment Market Share by Country (2016-2021)
  • Table 64. Pfizer Company Details
  • Table 65. Pfizer Premature Ejaculation Treatment Product
  • Table 66. Pfizer Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 67. Pfizer Key Product Marketing Strategy
  • Table 68. Bayer Company Details
  • Table 69. Bayer Premature Ejaculation Treatment Product
  • Table 70. Bayer Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 71. Bayer Key Product Marketing Strategy
  • Table 72. Novartis Company Details
  • Table 73. Novartis Premature Ejaculation Treatment Product
  • Table 74. Novartis Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 75. Novartis Key Product Marketing Strategy
  • Table 76. Vivus Company Details
  • Table 77. Vivus Premature Ejaculation Treatment Product
  • Table 78. Vivus Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 79. Vivus Key Product Marketing Strategy
  • Table 80. Menarini Company Details
  • Table 81. Menarini Premature Ejaculation Treatment Product
  • Table 82. Menarini Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 83. Menarini Key Product Marketing Strategy
  • Table 84. Eli Lilly Company Details
  • Table 85. Eli Lilly Premature Ejaculation Treatment Product
  • Table 86. Eli Lilly Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 87. Eli Lilly Key Product Marketing Strategy
  • Table 88. Johnson & Johnson Company Details
  • Table 89. Johnson & Johnson Premature Ejaculation Treatment Product
  • Table 90. Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 91. Johnson & Johnson Key Product Marketing Strategy
  • Table 92. GlaxoSmithKline Company Details
  • Table 93. GlaxoSmithKline Premature Ejaculation Treatment Product
  • Table 94. GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 95. GlaxoSmithKline Key Product Marketing Strategy
  • Table 96. Torrent Pharma Company Details
  • Table 97. Torrent Pharma Premature Ejaculation Treatment Product
  • Table 98. Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 99. Torrent Pharma Key Product Marketing Strategy
  • Table 100. Teva Company Details
  • Table 101. Teva Premature Ejaculation Treatment Product
  • Table 102. Teva Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 103. Teva Key Product Marketing Strategy
  • Table 104. Sunrise Pharma Company Details
  • Table 105. Sunrise Pharma Premature Ejaculation Treatment Product
  • Table 106. Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 107. Sunrise Pharma Key Product Marketing Strategy
  • Table 108. Regent Pacific Company Details
  • Table 109. Regent Pacific Premature Ejaculation Treatment Product
  • Table 110. Regent Pacific Revenue in Premature Ejaculation Treatment Business (2016-2021) & (US$ Million)
  • Table 111. Regent Pacific Key Product Marketing Strategy
  • Table 112. Research Programs/Design for This Report
  • Table 113. Key Data Information from Secondary Sources
  • Table 114. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Premature Ejaculation Treatment Market Share by Type: 2021 VS 2027
  • Figure 2. Antidepressants(SSRIs) Features
  • Figure 3. Phosphodiesterase-5 Inhibitors Features
  • Figure 4. Topical Anesthetics Features
  • Figure 5. Other Treatment Features
  • Figure 6. Global Premature Ejaculation Treatment Market Share by Application: 2021 VS 2027
  • Figure 7. Hospital Case Studies
  • Figure 8. Retail Pharmacy Case Studies
  • Figure 9. Online Pharmacy Case Studies
  • Figure 10. Other Case Studies
  • Figure 11. Premature Ejaculation Treatment Report Years Considered
  • Figure 12. Global Premature Ejaculation Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
  • Figure 13. Global Premature Ejaculation Treatment Market Size, (US$ Million), 2016 VS 2021 VS 2027
  • Figure 14. Global Premature Ejaculation Treatment Market Share by Regions: 2021 VS 2027
  • Figure 15. Global Premature Ejaculation Treatment Market Share by Regions (2022-2027)
  • Figure 16. Taiwan Premature Ejaculation Treatment Market Share in Global Market 2016-2027
  • Figure 17. Patient Journey Mapping
  • Figure 18. Global Premature Ejaculation Treatment Market Share by Players in 2020
  • Figure 19. Global Top Premature Ejaculation Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Premature Ejaculation Treatment as of 2020)
  • Figure 20. The Top 5 Players Market Share by Premature Ejaculation Treatment Revenue in 2020
  • Figure 21. North America Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 22. United States Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 23. Canada Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 24. Europe Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 25. Germany Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 26. France Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 27. U.K. Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 28. Italy Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 29. Russia Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 30. Asia-Pacific Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 31. China Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 32. Japan Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 33. South Korea Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 34. Southeast Asia Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 35. India Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 36. Taiwan Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 37. Latin America Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 38. Mexico Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 39. Brazil Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 40. Middle East & Africa Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 41. Middle East Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 42. Africa Premature Ejaculation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 43. Pfizer Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 44. Bayer Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 45. Novartis Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 46. Vivus Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 47. Menarini Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 48. Eli Lilly Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 49. Johnson & Johnson Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 50. GlaxoSmithKline Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 51. Torrent Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 52. Teva Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 53. Sunrise Pharma Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 54. Regent Pacific Revenue Growth Rate in Premature Ejaculation Treatment Business (2016-2021)
  • Figure 55. Bottom-up and Top-down Approaches for This Report
  • Figure 56. Data Triangulation
  • Figure 57. Key Executives Interviewed 104

Market Analysis and Insights:

This report focuses on global and Taiwan Premature Ejaculation Treatment market.

In 2020, the global Premature Ejaculation Treatment market size was US$ 2646.48 million and it is expected to reach US$ 4865.10 million by the end of 2027, with a CAGR of 9.23% during 2021-2027. In Taiwan the Premature Ejaculation Treatment market size is expected to grow from US$ 18.18 million in 2020 to US$ 41.14 million by 2027, at a CAGR of 12.89% during the forecast period.

Scope and Market Size:

Premature Ejaculation Treatment market is segmented by players, region (country), by Type, and By Application. Players, stakeholders, and other participants in the global Premature Ejaculation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and By Application in terms of revenue and forecast for the period 2016-2027.

By Company

  • Pfizer
  • Bayer
  • Novartis
  • Vivus
  • Menarini
  • Eli Lilly
  • Johnson & Johnson
  • GlaxoSmithKline
  • Torrent Pharma
  • Teva
  • Sunrise Pharma
  • Regent Pacific

Segment by Type

  • Antidepressants(SSRIs)
  • Phosphodiesterase-5 Inhibitors
  • Topical Anesthetics
  • Other Treatment

Segment by Application

  • Hospital
  • Retail Pharmacy
  • Online Pharmacy
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Taiwan
    • Rest of APAC
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Middle East
    • Africa

TABLE OF CONTENTS

1 REPORT OVERVIEW

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Premature Ejaculation Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Antidepressants(SSRIs)
    • 1.2.3 Phosphodiesterase-5 Inhibitors
    • 1.2.4 Topical Anesthetics
    • 1.2.5 Other Treatment
  • 1.3 Market by Application
    • 1.3.1 Global Premature Ejaculation Treatment Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital
    • 1.3.3 Retail Pharmacy
    • 1.3.4 Online Pharmacy
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 GLOBAL GROWTH TRENDS

  • 2.1 Global Premature Ejaculation Treatment Market Perspective (2016-2027)
  • 2.2 Premature Ejaculation Treatment Growth Trends by Regions
    • 2.2.1 Premature Ejaculation Treatment Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Premature Ejaculation Treatment Historic Market Size by Regions (2016-2021)
    • 2.2.3 Premature Ejaculation Treatment Forecasted Market Size by Regions (2022-2027)
    • 2.2.4 Taiwan Premature Ejaculation Treatment Market Share in Global Market 2016-2027
  • 2.3 Premature Ejaculation Treatment Industry Dynamic
    • 2.3.1 Premature Ejaculation Treatment Trends & Premature Ejaculation Market Trends
    • 2.3.2 Premature Ejaculation Treatment Market Drivers
    • 2.3.3 Premature Ejaculation Treatment Market Challenges
    • 2.3.4 Premature Ejaculation Treatment Market Restraints

3 MICRO-ENVIRONMENT ANALYSIS

  • 3.1 Asia Market Analysis
  • 3.2 Taiwan Market Analysis
  • 3.3 Global and Region Premature Ejaculation Data Facts
  • 3.4 Patient Journey Mapping

4 COMPETITION LANDSCAPE BY KEY PLAYERS

  • 4.1 Global Top Premature Ejaculation Treatment Players by Revenue
    • 4.1.1 Global Top Premature Ejaculation Treatment Players by Revenue (2016-2021)
    • 4.1.2 Global Premature Ejaculation Treatment Revenue Market Share by Players (2016-2021)
  • 4.2 Global Premature Ejaculation Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 4.3 Players Covered: Ranking by Premature Ejaculation Treatment Revenue
  • 4.4 Global Premature Ejaculation Treatment Market Concentration Ratio
    • 4.4.1 Global Premature Ejaculation Treatment Market Concentration Ratio (CR5 and HHI)
    • 4.4.2 Global Top 5 Companies by Premature Ejaculation Treatment Revenue in 2020
  • 4.5 Premature Ejaculation Treatment Key Players Head office and Area Served
  • 4.6 Key Players Premature Ejaculation Treatment Product Solution and Service
  • 4.7 Date of Enter into Premature Ejaculation Treatment Market
  • 4.8 Mergers & Acquisitions, Expansion Plans

5 PREMATURE EJACULATION TREATMENT BREAKDOWN DATA BY TYPE

  • 5.1 Global Premature Ejaculation Treatment Historic Market Size by Type (2016-2021)
  • 5.2 Global Premature Ejaculation Treatment Forecasted Market Size by Type (2022-2027)

6 PREMATURE EJACULATION TREATMENT BREAKDOWN DATA BY APPLICATION

  • 6.1 Global Premature Ejaculation Treatment Historic Market Size by Application (2016-2021)
  • 6.2 Global Premature Ejaculation Treatment Forecasted Market Size by Application (2022-2027)

7 NORTH AMERICA

  • 7.1 North America Premature Ejaculation Treatment Market Size (2016-2027)
  • 7.2 North America Premature Ejaculation Treatment Market Size by Type (2016-2021)
  • 7.3 North America Premature Ejaculation Treatment Market Size by Application (2016-2021)
  • 7.4 North America Premature Ejaculation Treatment Market Size by Country (2016-2021)
    • 7.4.1 United States
    • 7.4.2 Canada

8 EUROPE

  • 8.1 Europe Premature Ejaculation Treatment Market Size (2016-2027)
  • 8.2 Europe Premature Ejaculation Treatment Market Size by Type (2016-2021)
  • 8.3 Europe Premature Ejaculation Treatment Market Size by Application (2016-2021)
  • 8.4 Europe Premature Ejaculation Treatment Market Size by Country (2016-2021)
    • 8.4.1 Germany
    • 8.4.2 France
    • 8.4.3 U.K.
    • 8.4.4 Italy
    • 8.4.5 Russia

9 ASIA-PACIFIC

  • 9.1 Asia-Pacific Premature Ejaculation Treatment Market Size (2016-2027)
  • 9.2 Asia-Pacific Premature Ejaculation Treatment Market Size by Type (2016-2021)
  • 9.3 Asia-Pacific Premature Ejaculation Treatment Market Size by Application (2016-2021)
  • 9.4 Asia-Pacific Premature Ejaculation Treatment Market Size by Region (2016-2021)
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 South Korea
    • 9.4.4 Southeast Asia
    • 9.4.5 India
    • 9.4.6 Taiwan

10 LATIN AMERICA

  • 10.1 Latin America Premature Ejaculation Treatment Market Size (2016-2027)
  • 10.2 Latin America Premature Ejaculation Treatment Market Size by Type (2016-2021)
  • 10.3 Latin America Premature Ejaculation Treatment Market Size by Application (2016-2021)
  • 10.4 Latin America Premature Ejaculation Treatment Market Size by Country (2016-2021)
    • 10.4.1 Mexico
    • 10.4.2 Brazil

11 MIDDLE EAST & AFRICA

  • 11.1 Middle East & Africa Premature Ejaculation Treatment Market Size (2016-2027)
  • 11.2 Middle East & Africa Premature Ejaculation Treatment Market Size by Type (2016-2021)
  • 11.3 Middle East & Africa Premature Ejaculation Treatment Market Size by Application (2016-2021)
  • 11.4 Middle East & Africa Premature Ejaculation Treatment Market Size by Country (2016-2021)
    • 11.4.1 Middle East
    • 11.4.2 Africa

12 KEY PLAYERS PROFILES

  • 12.1 Pfizer
    • 12.1.1 Pfizer Company Details
    • 12.1.2 Pfizer Business Overview
    • 12.1.3 Pfizer Premature Ejaculation Treatment Introduction
    • 12.1.4 Pfizer Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.1.5 Pfizer Key Product Marketing Strategy
  • 12.2 Bayer
    • 12.2.1 Bayer Company Details
    • 12.2.2 Bayer Business Overview
    • 12.2.3 Bayer Premature Ejaculation Treatment Introduction
    • 12.2.4 Bayer Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.2.5 Bayer Key Product Marketing Strategy
  • 12.3 Novartis
    • 12.3.1 Novartis Company Details
    • 12.3.2 Novartis Business Overview
    • 12.3.3 Novartis Premature Ejaculation Treatment Introduction
    • 12.3.4 Novartis Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.3.5 Novartis Key Product Marketing Strategy
  • 12.4 Vivus
    • 12.4.1 Vivus Company Details
    • 12.4.2 Vivus Business Overview
    • 12.4.3 Vivus Premature Ejaculation Treatment Introduction
    • 12.4.4 Vivus Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.4.5 Vivus Key Product Marketing Strategy
  • 12.5 Menarini
    • 12.5.1 Menarini Company Details
    • 12.5.2 Menarini Business Overview
    • 12.5.3 Menarini Premature Ejaculation Treatment Introduction
    • 12.5.4 Menarini Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.5.5 Menarini Key Product Marketing Strategy
  • 12.6 Eli Lilly
    • 12.6.1 Eli Lilly Company Details
    • 12.6.2 Eli Lilly Business Overview
    • 12.6.3 Eli Lilly Premature Ejaculation Treatment Introduction
    • 12.6.4 Eli Lilly Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.6.5 Eli Lilly Key Product Marketing Strategy
  • 12.7 Johnson & Johnson
    • 12.7.1 Johnson & Johnson Company Details
    • 12.7.2 Johnson & Johnson Business Overview
    • 12.7.3 Johnson & Johnson Premature Ejaculation Treatment Introduction
    • 12.7.4 Johnson & Johnson Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.7.5 Johnson & Johnson Key Product Marketing Strategy
  • 12.8 GlaxoSmithKline
    • 12.8.1 GlaxoSmithKline Company Details
    • 12.8.2 GlaxoSmithKline Business Overview
    • 12.8.3 GlaxoSmithKline Premature Ejaculation Treatment Introduction
    • 12.8.4 GlaxoSmithKline Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.8.5 GlaxoSmithKline Key Product Marketing Strategy
  • 12.9 Torrent Pharma
    • 12.9.1 Torrent Pharma Company Details
    • 12.9.2 Torrent Pharma Business Overview
    • 12.9.3 Torrent Pharma Premature Ejaculation Treatment Introduction
    • 12.9.4 Torrent Pharma Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.9.5 Torrent Pharma Key Product Marketing Strategy
  • 12.10 Teva
    • 12.10.1 Teva Company Details
    • 12.10.2 Teva Business Overview
    • 12.10.3 Teva Premature Ejaculation Treatment Introduction
    • 12.10.4 Teva Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.10.5 Teva Key Product Marketing Strategy
  • 12.11 Sunrise Pharma
    • 12.11.1 Sunrise Pharma Company Details
    • 12.11.2 Sunrise Pharma Business Overview
    • 12.11.3 Sunrise Pharma Premature Ejaculation Treatment Introduction
    • 12.11.4 Sunrise Pharma Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.11.5 Sunrise Pharma Key Product Marketing Strategy
  • 12.12 Regent Pacific
    • 12.12.1 Regent Pacific Company Details
    • 12.12.2 Regent Pacific Business Overview
    • 12.12.3 Regent Pacific Premature Ejaculation Treatment Introduction
    • 12.12.4 Regent Pacific Revenue in Premature Ejaculation Treatment Business (2016-2021)
    • 12.12.5 Regent Pacific Key Product Marketing Strategy

13 ANALYST'S VIEWPOINTS/CONCLUSIONS

14 APPENDIX

  • 14.1 Research Methodology
    • 14.1.1 Methodology/Research Approach
    • 14.1.2 Data Source
  • 14.2 Disclaimer
  • 14.3 Author Details
Back to Top
전화 문의
F A Q